Compounds > amphetamine

amphetamine and glucagon-like peptide 1

amphetamine has been researched along with glucagon-like peptide 1 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, AR; Erreger, K; Galli, A; Greig, NH; Poe, AM; Stanwood, GD1
Egecioglu, E; Engel, JA; Jerlhag, E1

Other Studies

2 other study(ies) available for amphetamine and glucagon-like peptide 1

ArticleYear
Exendin-4 decreases amphetamine-induced locomotor activity.
    Physiology & behavior, 2012, Jun-25, Volume: 106, Issue:4

    Topics: Amphetamine; Animals; Antimanic Agents; Anxiety; Central Nervous System Stimulants; Conditioning, Operant; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Lithium Chloride; Male; Motor Activity; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Venoms

2012
The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice.
    PloS one, 2013, Volume: 8, Issue:7

    Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cocaine; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Liraglutide; Male; Mice; Motor Activity; Peptides; Receptors, Glucagon; Venoms

2013